WebMD News Brief

2 Manufacturers Recall Eyedrops Over Safety Concerns

man using eye drops

March 7, 2023 -- Two manufacturers of eyedrops have recalled products over fears about contamination and sterility.

The FDA issued recall notices last week for eyedrops made by Pharmedica and Apotex after the companies said they were voluntarily recalling the products.

“Use of contaminated eye drops can result in the risk of eye infections that could result in blindness,” Pharmedica said about some of its Purely Soothing 15% MSM Drops. The company urged consumers to stop using the drops and return them to the point of purchase. They are sold over the counter to treat eye irritation.

The recall affects about 3,000 bottles of product made in Arizona. The FDA said there have been no reports of injury.

Apotex is recalling some of its glaucoma drops distributed as Brimonidine Tartrate Ophthalmic Solution, 0.15% and sold from last April through February. 

The company said it found cracks in a few bottle caps. No injuries have been reported. The eyedrops were made in Canada. 

“This recall is being initiated out of an abundance of caution,” the company said, urging consumers to contact their pharmacies and healthcare providers if they think they have the affected product.

Eyedrops made in India were recalled last month after being linked to drug-resistant infections that killed at least one person and left five with permanent vision loss, according to The Associated Press.

The AP aid there has been non link between those products and the ones made by Pharmedica and Apotex.

Show Sources

FDA: “Apotex Corp. Issues Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution, 0.15% Due to Cracks that Have Developed in Some of the Units Caps of the Bottles”

AP: “Two more eyedrop brands recalled due to risks”

FDA: “Pharmedica USA LLC Issues Voluntary Worldwide Recall of Purely Soothing 15% MSM Drops Due to Non-Sterility”

© 2023 WebMD, LLC. All rights reserved. View privacy policy and trust info